Maxillary osteonecrosis induced by antiresorptive medication (bisphosphonate) in a patient with multiple myeloma - Case report
Keywords:Osteonecrose; Maxila; Biphosphonate- associated osteonecrosis of the jaw.
Objective: to describe the clinical case of a patient with multiple myeloma, who developed maxillary osteonecrosis induced by anti-resorptive medication (bisphosphonate) submitted to a conservative and surgical therapeutic approach and subsequent prosthetic rehabilitation. Patients and methods: the case report is presented based on a simple review of the literature and clinical experience for the diagnosis, clinical staging of the lesion, carrying out the excision of the necrotic bone, debridement, lesion control and making a obturator prosthesis. Results: Despite the difficulty offered by the pathological condition and continuous use of medication, the treatment employed was successful, restoring health and providing a better quality of life to the patient, which allowed the obturation prosthesis to be made in the 8-month postoperative period. Conclusion: The result obtained emphasizes the importance of knowledge of the staging of the lesion for the application of the treatment protocol, in addition to recognizing patients at risk for the practice of prevention in dental treatments.
Arantes, H. P., Silva, A. G., & Lazaretti-Castro, M. (2010). Bisphosphonates in the treatment of metabolic bone diseases. Arquivos brasileiros de endocrinologia e metabologia, 54(2), 206–212. https://doi.org/10.1590/s0004-27302010000200017
Conte-Neto, N., Bastos, A. S., Spolidorio, L. C., Marcantonio, R. A., & Marcantonio, E., Jr (2011). Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports. Head & face medicine, 7, 7. https://doi.org/10.1186/1746-160X-7-7
Curi, M. M., Cossolin, G. S., Koga, D. H., Zardetto, C., Christianini, S., Feher, O., Cardoso, C. L., & dos Santos, M. O. (2011). Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 69(9), 2465–2472. https://doi.org/10.1016/j.joms.2011.02.078
Escobedo, M. F., Cobo, J. L., Junquera, S., Milla, J., Olay, S., & Junquera, L. M. (2020). Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. Journal of stomatology, oral and maxillofacial surgery, 121(1), 40–48. https://doi.org/10.1016/j.jormas.2019.04.012
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M., & Otto, S. (2015). Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. International journal of oral and maxillofacial surgery, 44(5), 568–585. https://doi.org/10.1016/j.ijom.2015.01.026
Griz, L. C. G, Bandeira, C, Assunção, V, & Bandeira, F. (2006). Paget's disease of bone. Arquivos Brasileiros de Endocrinologia & Metabologia, 50(4), 814-822. https://doi.org/10.1590/S0004-27302006000400026
Guazzo, R., Sbricoli, L., Ricci, S., Bressan, E., Piattelli, A., & Iaculli, F. (2017). Medication-Related Osteonecrosis of the Jaw and Dental Implants Failures: A Systematic Review. The Journal of oral implantology, 43(1), 51–57. https://doi.org/10.1563/aaid-joi-16-00057
Kos, M., Kuebler, J. F., Luczak, K., & Engelke, W. (2010). Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery, 38(4), 255–259. https://doi.org/10.1016/j.jcms.2009.06.005
Krstevska, S., Stavric, S. G., Cevrevska, L., Georgjievski, B., Karanfilski, O., Sotirova, T., & Balkanov, T. (2015). Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma. Medical archives (Sarajevo, Bosnia and Herzegovina), 69(6), 367–370. https://doi.org/10.5455/medarh.2015.69.367-370
Marx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005). Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 63(11), 1567–1575. https://doi.org/10.1016/j.joms.2005.07.010
Marx R. E. (2009). Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 67(5 Suppl), 107–119. https://doi.org/10.1016/j.joms.2008.12.007
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004). Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 62(5), 527–534. https://doi.org/10.1016/j.joms.2004.02.004
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 72(10), 1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Russell, R. G., Watts, N. B., Ebetino, F. H., Rogers, M. J. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008; 19(6), 733-759. doi:10.1007/s00198-007-0540-8
Wang, J., Goodger, N. M., & Pogrel, M. A. (2003). Osteonecrosis of the jaws associated with cancer chemotherapy. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 61(9), 1104–1107. https://doi.org/10.1016/s0278-2391(03)00328-8
Wang, E. P., Kaban, L. B., Strewler, G. J., Raje, N., & Troulis, M. J. (2007). Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 65(7), 1328–1331. https://doi.org/10.1016/j.joms.2007.03.006
Zervas, K., Verrou, E., Teleioudis, Z., Vahtsevanos, K., Banti, A., Mihou, D., Krikelis, D., & Terpos, E. (2006). Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. British journal of haematology, 134(6), 620–623. https://doi.org/10.1111/j.1365-2141.2006.06230.x
How to Cite
Copyright (c) 2020 Patrick Rocha Osborne; Bruno Mendes; Leonardo Perez Faverani; Cleber Nunes Alexandre; Giorge Pessoa de Jesus
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.